Impact of cardiovascular risk factors on medical expenditure: evidence from epidemiological studies analysing data on health checkups and medical insurance.

Discussion of "Representation of People's Decisions in Health Information Systems: A Complementary Approach for Understanding Health Care Systems and Population Health". Methods Inf Med (2017) 0.85

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28

Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 70.59

Sick individuals and sick populations. Int J Epidemiol (1985) 23.44

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09

New criteria for 'obesity disease' in Japan. Circ J (2002) 6.19

Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes (1992) 3.27

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med (1989) 2.63

Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults. Lancet (1972) 1.61

Effect of combined cardiovascular risk factors on individual and population medical expenditures: a 10-year cohort study of national health insurance in a Japanese population. Circ J (2007) 1.52

Treated and untreated hypertension, hospitalization, and medical expenditure: an epidemiological study in 314622 beneficiaries of the medical insurance system in Japan. J Hypertens (2013) 1.50

The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int Heart J (2008) 1.30

Weight change, body weight and mortality: the impact of smoking and ill health. Int J Epidemiol (2001) 1.21

Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes (1995) 1.09

Case-mix payment in Japanese medical care. Health Policy (2005) 0.97

Impact of hypertension on medical economics: A 10-year follow-up study of national health insurance in Shiga, Japan. Hypertens Res (2005) 0.96

The value of combining serum alanine aminotransferase levels and body mass index to predict mortality and medical costs: a 10-year follow-up study of National Health Insurance in Shiga, Japan. J Epidemiol (2006) 0.88

Medical expenditures of men with hypertension and/or a smoking habit: a 10-year follow-up study of National Health Insurance in Shiga, Japan. Hypertens Res (2010) 0.87

Medical costs of obese Japanese: a 10-year follow-up study of National Health Insurance in Shiga, Japan. Eur J Public Health (2007) 0.87

Medical costs of patients with hypertension and/or diabetes: A 10-year follow-up study of National Health Insurance in Shiga, Japan. J Hypertens (2006) 0.86

Health insurance and payment systems for severe acute pancreatitis. J Hepatobiliary Pancreat Sci (2009) 0.84

Medical expenditure for diabetic patients: a 10-year follow-up study of National Health Insurance in Shiga, Japan. Public Health (2008) 0.83

The clustering of cardiovascular disease risk factors and their impacts on annual medical expenditure in Japan: community-based cost analysis using Gamma regression models. BMJ Open (2013) 0.82

[The influence of alcohol drinking on medical care expenditures among National Health Insurance beneficiaries]. Nihon Arukoru Yakubutsu Igakkai Zasshi (2005) 0.82

Nicotine dependence and cost-effectiveness of individualized support for smoking cessation: evidence from practice at a worksite in Japan. PLoS One (2013) 0.81

Medical costs of individuals with proteinuria: A 10-year follow-up study of National Health Insurance in Shiga, Japan. Public Health (2006) 0.77